TY - JOUR
T1 - Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON
AU - Dingemans, A.J.M.
AU - Truijen, K.M.G.
AU - Kim, J.H.
AU - Alacam, Z.
AU - Faivre, L.
AU - Collins, K.M.
AU - Gerkes, E.H.
AU - van Haelst, M.
AU - van de Laar, I.M.B.H.
AU - Lindstrom, K.
AU - Nizon, M.
AU - Pauling, J.
AU - Heropolitanska-Pliszka, E.
AU - Plomp, A.S.
AU - Racine, C.
AU - Sachdev, R.
AU - Sinnema, M.
AU - Skranes, J.
AU - Veenstra-Knol, H.E.
AU - Verberne, E.A.
AU - Vulto-van Silfhout, A.T.
AU - Wilsterman, M.E.F.
AU - Ahn, E.Y.E.
AU - de Vries, B.B.A.
AU - Vissers, L.E.L.M.
N1 - Funding Information:
First and foremost, we are grateful to all individuals and their parents for participation in this study. Next to that, we are grateful to the Dutch Organisation for Health Research and Development: ZON-MW grants 912-12-109 (to BBAdV and LELMV), Donders Junior researcher grant 2019 (to BBAdV and LELMV) and Aspasia grant 015.014.066 (to LELMV). This study was also supported by the US National Institute of Health grants R01 CA190688 and R01 CA236911 (to E-YEA). This work has been generated through a collaboration with the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability (ERN-ITHACA) [EU Frame-work Partnership Agreement ID: 3HP-HP-FPA ERN-01-2016/739516]. The aims of this study contribute to the Solve-RD project (to LELMV) that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 779257.
Funding Information:
First and foremost, we are grateful to all individuals and their parents for participation in this study. Next to that, we are grateful to the Dutch Organisation for Health Research and Development: ZON-MW grants 912-12-109 (to BBAdV and LELMV), Donders Junior researcher grant 2019 (to BBAdV and LELMV) and Aspasia grant 015.014.066 (to LELMV). This study was also supported by the US National Institute of Health grants R01 CA190688 and R01 CA236911 (to E-YEA). This work has been generated through a collaboration with the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability (ERN-ITHACA) [EU Framework Partnership Agreement ID: 3HP-HP-FPA ERN-01-2016/739516]. The aims of this study contribute to the Solve-RD project (to LELMV) that has received funding from the European Union?s Horizon 2020 research and innovation programme under grant agreement No 779257.
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to European Society of Human Genetics.
PY - 2022/3
Y1 - 2022/3
N2 - Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome, an intellectual disability syndrome first described in 2016, is caused by heterozygous loss-of-function variants in SON. Its encoded protein promotes pre-mRNA splicing of many genes essential for development. Whereas individual phenotypic traits have previously been linked to erroneous splicing of SON target genes, the phenotypic spectrum and the pathogenicity of missense variants have not been further evaluated. We present the phenotypic abnormalities in 52 individuals, including 17 individuals who have not been reported before. In total, loss-of-function variants were detected in 49 individuals (de novo in 47, inheritance unknown in 2), and in 3, a missense variant was observed (2 de novo, 1 inheritance unknown). Phenotypic abnormalities, systematically collected and analyzed in Human Phenotype Ontology, were found in all organ systems. Significant inter-individual phenotypic variability was observed, even in individuals with the same recurrent variant (n = 13). SON haploinsufficiency was previously shown to lead to downregulation of downstream genes, contributing to specific phenotypic features. Similar functional analysis for one missense variant, however, suggests a different mechanism than for heterozygous loss-of-function. Although small in numbers and while pathogenicity of these variants is not certain, these data allow for speculation whether de novo missense variants cause ZTTK syndrome via another mechanism, or a separate overlapping syndrome. In conclusion, heterozygous loss-of-function variants in SON define a recognizable syndrome, ZTTK, associated with a broad, severe phenotypic spectrum, characterized by a large inter-individual variability. These observations provide essential information for affected individuals, parents, and healthcare professionals to ensure appropriate clinical management.
AB - Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome, an intellectual disability syndrome first described in 2016, is caused by heterozygous loss-of-function variants in SON. Its encoded protein promotes pre-mRNA splicing of many genes essential for development. Whereas individual phenotypic traits have previously been linked to erroneous splicing of SON target genes, the phenotypic spectrum and the pathogenicity of missense variants have not been further evaluated. We present the phenotypic abnormalities in 52 individuals, including 17 individuals who have not been reported before. In total, loss-of-function variants were detected in 49 individuals (de novo in 47, inheritance unknown in 2), and in 3, a missense variant was observed (2 de novo, 1 inheritance unknown). Phenotypic abnormalities, systematically collected and analyzed in Human Phenotype Ontology, were found in all organ systems. Significant inter-individual phenotypic variability was observed, even in individuals with the same recurrent variant (n = 13). SON haploinsufficiency was previously shown to lead to downregulation of downstream genes, contributing to specific phenotypic features. Similar functional analysis for one missense variant, however, suggests a different mechanism than for heterozygous loss-of-function. Although small in numbers and while pathogenicity of these variants is not certain, these data allow for speculation whether de novo missense variants cause ZTTK syndrome via another mechanism, or a separate overlapping syndrome. In conclusion, heterozygous loss-of-function variants in SON define a recognizable syndrome, ZTTK, associated with a broad, severe phenotypic spectrum, characterized by a large inter-individual variability. These observations provide essential information for affected individuals, parents, and healthcare professionals to ensure appropriate clinical management.
KW - INTELLECTUAL-DISABILITY
U2 - 10.1038/s41431-021-00960-4
DO - 10.1038/s41431-021-00960-4
M3 - Article
C2 - 34521999
SN - 1018-4813
VL - 30
SP - 271
EP - 281
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
IS - 3
ER -